• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

褪黑素对人乳腺癌细胞的生长抑制作用与雌激素反应系统有关。

The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system.

作者信息

Hill S M, Spriggs L L, Simon M A, Muraoka H, Blask D E

机构信息

Tulane University, School of Medicine, Department of Anatomy, New Orleans, Louisiana 70112.

出版信息

Cancer Lett. 1992 Jul 10;64(3):249-56. doi: 10.1016/0304-3835(92)90050-6.

DOI:10.1016/0304-3835(92)90050-6
PMID:1638517
Abstract

The pineal hormone, melatonin, was examined for its capacity to modulate the proliferation of a panel of human breast cancer cell lines. Melatonin inhibited, to a varying extent, the proliferation of all three estrogen-responsive cell lines, but had no effect on estrogen-insensitive breast tumor cell lines. Melatonin was also able to specifically block estrogen-induced proliferation in MCF-7 breast cancer cells. However, this action was abolished in the presence of tamoxifen. Therefore, it appears that the antiproliferative effects of melatonin are mediated through the estrogen-response pathway.

摘要

对松果体激素褪黑素调节一组人乳腺癌细胞系增殖的能力进行了研究。褪黑素在不同程度上抑制了所有三种雌激素反应性细胞系的增殖,但对雌激素不敏感的乳腺肿瘤细胞系没有影响。褪黑素还能够特异性地阻断MCF-7乳腺癌细胞中雌激素诱导的增殖。然而,在他莫昔芬存在的情况下,这种作用被消除。因此,褪黑素的抗增殖作用似乎是通过雌激素反应途径介导的。

相似文献

1
The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system.褪黑素对人乳腺癌细胞的生长抑制作用与雌激素反应系统有关。
Cancer Lett. 1992 Jul 10;64(3):249-56. doi: 10.1016/0304-3835(92)90050-6.
2
Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.ICI 164,384和ICI 182,780对4-羟基他莫昔芬耐药的人乳腺癌细胞的抗增殖和抗雌激素作用
Int J Cancer. 1994 Jan 15;56(2):295-300. doi: 10.1002/ijc.2910560225.
3
Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.雌激素调节基因在他莫昔芬耐药以及对ICI 164,384和ICI 182,780敏感的人乳腺癌细胞系MCF-7/TAMR-1中的表达改变。
Cancer Res. 1994 Mar 15;54(6):1587-95.
4
Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment.对纯抗雌激素耐药的人乳腺癌细胞系对他莫昔芬治疗敏感。
Int J Cancer. 1995 May 16;61(4):529-34. doi: 10.1002/ijc.2910610417.
5
Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.4-羟基他莫昔芬及新型纯抗雌激素药物(ICI 182780)对人乳腺癌细胞体外克隆生长的影响
Br J Cancer. 1994 Aug;70(2):204-11. doi: 10.1038/bjc.1994.281.
6
[Antitumor activity of miproxifene phosphate (TAT-59) against human mammary carcinoma].磷酸米普昔芬(TAT-59)对人乳腺癌的抗肿瘤活性
Gan To Kagaku Ryoho. 1998 May;25(6):829-38.
7
Bidirectional interactions between the estrogen receptor and the cerbB-2 signaling pathways: heregulin inhibits estrogenic effects in breast cancer cells.雌激素受体与cerbB-2信号通路之间的双向相互作用:神经调节蛋白抑制乳腺癌细胞中的雌激素效应。
Int J Cancer. 1995 Nov 15;63(4):560-7. doi: 10.1002/ijc.2910630417.
8
Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.来曲唑、阿那曲唑和他莫昔芬对雌激素受体阳性和芳香化酶阳性人乳腺癌细胞单层及球体培养物的生长抑制作用。
J Steroid Biochem Mol Biol. 2005 Dec;97(4):360-8. doi: 10.1016/j.jsbmb.2005.09.003. Epub 2005 Nov 2.
9
MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells.褪黑素(MT)1型受体过表达增强了褪黑素对人乳腺癌细胞的生长抑制作用。
Mol Cell Endocrinol. 2002 Jun 28;192(1-2):147-56. doi: 10.1016/s0303-7207(02)00029-1.
10
Direct antiproliferative effect of triptorelin on human breast cancer cells.
Anticancer Res. 1994 Sep-Oct;14(5A):1881-5.

引用本文的文献

1
Melatonin and Breast Cancer: A Review Article.褪黑素与乳腺癌:一篇综述文章。
Chonnam Med J. 2025 May;61(2):63-74. doi: 10.4068/cmj.2025.61.2.63. Epub 2025 May 23.
2
Anticancer Drug Conjugates Incorporating Estrogen Receptor Ligands.包含雌激素受体配体的抗癌药物缀合物
Pharmaceutics. 2022 Dec 26;15(1):67. doi: 10.3390/pharmaceutics15010067.
3
Melatonin in Endometriosis: Mechanistic Understanding and Clinical Insight.内异症中的褪黑素:机制理解与临床启示。
Nutrients. 2022 Oct 1;14(19):4087. doi: 10.3390/nu14194087.
4
Melatonin and its mechanism of action in the female reproductive system and related malignancies.褪黑素及其在女性生殖系统和相关恶性肿瘤中的作用机制。
Mol Cell Biochem. 2021 Aug;476(8):3177-3190. doi: 10.1007/s11010-021-04151-z. Epub 2021 Apr 17.
5
Potential Role of Lycopene in the Prevention of Postmenopausal Bone Loss: Evidence from Molecular to Clinical Studies.番茄红素在预防绝经后骨丢失中的作用:从分子到临床研究的证据。
Int J Mol Sci. 2020 Sep 27;21(19):7119. doi: 10.3390/ijms21197119.
6
Profile of melatonin and its receptors and synthesizing enzymes in cumulus-oocyte complexes of the developing sheep antral follicle-a potential estradiol-mediated mechanism.绵羊窦前卵泡卵丘-卵母细胞复合体中褪黑素及其受体和合成酶的特征——一种潜在的雌二醇介导的机制。
Reprod Biol Endocrinol. 2019 Jan 3;17(1):1. doi: 10.1186/s12958-018-0446-7.
7
Melatonin and Hippo Pathway: Is There Existing Cross-Talk?褪黑素与 Hippo 通路:是否存在交叉对话?
Int J Mol Sci. 2017 Sep 6;18(9):1913. doi: 10.3390/ijms18091913.
8
What is known about melatonin, chemotherapy and altered gene expression in breast cancer.关于褪黑素、化疗与乳腺癌中基因表达改变,我们了解多少?
Oncol Lett. 2017 Apr;13(4):2003-2014. doi: 10.3892/ol.2017.5712. Epub 2017 Feb 10.
9
The Reduction in Circulating Melatonin Level May Contribute to the Pathogenesis of Ovarian Cancer: A Retrospective Study.循环褪黑素水平降低可能与卵巢癌发病机制有关:一项回顾性研究。
J Cancer. 2016 Apr 27;7(7):831-6. doi: 10.7150/jca.14573. eCollection 2016.
10
Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression.褪黑素通过调节Rho相关激酶蛋白-1的表达来减少乳腺癌转移。
J Pineal Res. 2016 Jan;60(1):3-15. doi: 10.1111/jpi.12270. Epub 2015 Oct 20.